Celsius Holdings, Inc. (NASDAQ:CELH) shares are trading lower on Tuesday after the company released its first-quarter results. The beverage giant reported adjusted earnings per share of 18 cents, missing the analyst consensus estimate of 19 cents. Quarterly sales of $329.28 million (down 7% year over year) missed the street view of $344.03 million. CELSIUS brand retail sales declined 3% year over year with a dollar share of 10.9%, down 140 basis points from the prior year. Celsius highlighted that the revenue was affected by the timing and structure of our U.S. distributor incentive program and elevated retail promotional allowances, which were more heavily weighted toward the latter part of the quarter compared to the same period in 2024. Also Read:PepsiCo CEO Warns Of Tariffs Led ‘Increase In Supply Chain Costs,’ Cuts Annual Profit Outlook “While revenue was down year over year, retail scanner data showed a 2% increase in dollar sales for the 13 weeks ended Mar. 30, 2025, compared to the prior 13-week period,” the company said in a press release. The company’s adjusted EBITDA slumped 21% year over year to $69.7 million, while quarterly net income fell 43% to $44.4 million. Celsius closed the acquisition of Alani Nu on Apr. 1, 2025. Alani Nu surpassed $1 billion in trailing 52-week retail sales for the period ended Apr. 13. The company exited the quarter with cash and equivalents worth $977.285 million. Inventories-net totaled $141.159 million. Gross margin in the quarter under review expanded by 110 basis points to 52.3%. The increase in gross margin is attributed to sourcing efficiencies for raw and package materials. On a pro forma basis, Celsius said it captured 16.2% of U.S. energy drink category dollar share in the first quarter. Price Action: CELH shares are trading lower by 3.57% to $32.68 at the last check on Tuesday. Read Next: Trump Orders FDA To Fast-Track US Drug Production As Tariff Threat Looms On Imported Medicines: Cites National Security Concerns Photo by MDV Edwards via Shutterstock UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? CELSIUS HOLDINGS (CELH): Free Stock Analysis Report This article Celsius Stock Fizzles After Q1 Miss, Revenue Slide originally appeared on Benzinga.com © 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. View Comments
Celsius Stock Fizzles After Q1 Miss, Revenue Slide
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...